SIGA Technologies
SIGA
$8.96
Share price
2.05%
Change (1 day)
53.95%
Change (1 year)
Categories
P/S ratio for SIGA Technologies (SIGA)
P/S ratio as of May 2024 (TTM): 4.46
According to SIGA Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.46304. At the end of 2023 the company had a P/S ratio of 2.85.
P/S ratio history for SIGA Technologies from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.85 | -41.35% |
| 2022 | 4.85 | 16.36% |
| 2021 | 4.17 | -7.4% |
| 2020 | 4.50 | -68.86% |
| 2019 | 14.5 | 987.09% |
| 2018 | 1.33 | -95.74% |
| 2017 | 31.2 | 199.04% |
| 2016 | 10.4 | 275.24% |
| 2015 | 2.78 | -88.67% |
| 2014 | 24.5 | -22.01% |
| 2013 | 31.5 | 108.62% |
| 2012 | 15.1 | 48.13% |
| 2011 | 10.2 | -71.49% |
| 2010 | 35.7 | 97.5% |
| 2009 | 18.1 | 26.16% |
| 2008 | 14.3 | -8.15% |
| 2007 | 15.6 | -9.83% |
| 2006 | 17.3 | 482.66% |
| 2005 | 2.97 | -86.57% |
| 2004 | 22.1 | -62.17% |
| 2003 | 58.4 | 13.87% |
| 2002 | 51.3 | 102.4% |
| 2001 | 25.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | 9.63 | 115.71% | 🇺🇸 USA |
 Novavax NVAX | 0.8739 | -80.42% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 358 | 7,928.79% | 🇺🇸 USA |
 NanoViricides NNVC | N/A | N/A | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | 2.57 | -42.39% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.0962 | -97.84% | 🇺🇸 USA |